SRBio

SR Bio is a South Korean biotechnology company specializing in regenerative medicine through its proprietary Self-Regenerative Technology (SR-T). The company's platform is designed to activate endogenous stem cells in situ, offering a potential fundamental treatment for degenerative diseases without the need for external cell transplantation. SR Bio's primary therapeutic focus includes androgenetic alopecia, skin regeneration, and osteoarthritis. By leveraging its core research into stem cell niches and activation pathways, the company aims to develop both clinical-grade therapeutics and high-performance bioactive ingredients for the dermo-cosmetic industry. SR Bio is currently advancing its lead programs through pre-clinical development with the goal of entering clinical trials for hair loss and tissue repair.